| 2011 update of the drug resistance mutations in HIV-1 VA Johnson, V Calvez, HF Günthard, R Paredes, D Pillay, R Shafer, ... Topics in antiviral medicine 19 (4), 156, 2011 | 1200 | 2011 |
| Drug resistance mutations for surveillance of transmitted HIV-1 drug-resistance: 2009 update DE Bennett, RJ Camacho, D Otelea, DR Kuritzkes, H Fleury, M Kiuchi, ... PloS one 4 (3), e4724, 2009 | 971 | 2009 |
| 2017 update of the drug resistance mutations in HIV-1 AM Wensing, V Calvez, HF Günthard, VA Johnson, R Paredes, D Pillay, ... Topics in antiviral medicine 24 (4), 132, 2016 | 685 | 2016 |
| Antiretroviral drug resistance testing in adult HIV-1 infection: 2008 recommendations of an International AIDS Society-USA panel MS Hirsch, HF Günthard, JM Schapiro, FB Vézinet, B Clotet, SM Hammer, ... Clinical Infectious Diseases 47 (2), 266-285, 2008 | 610 | 2008 |
| Update of the Drug Resistance Mutations in HIV-1: 2005 VA Johnson, F Brun-Vézinet, B Clotet, B Conway, D Pillay, J Schapiro, ... Top. HIV Med 14 (3), 125-130, 2006 | 494 | 2006 |
| British HIV Association Guidelines for the treatment of HIV-1-infected adults with antiretroviral therapy 2008 BG Gazzard, J Anderson, A Babiker, M Boffito, G Brook, G Brough, ... HIV medicine 9 (8), 563-608, 2008 | 459 | 2008 |
| Global trends in antiretroviral resistance in treatment-naive individuals with HIV after rollout of antiretroviral treatment in resource-limited settings: a global … RK Gupta, MR Jordan, BJ Sultan, A Hill, DHJ Davis, J Gregson, ... The Lancet 380 (9849), 1250-1258, 2012 | 399 | 2012 |
| Effect of transmitted drug resistance on virological and immunological response to initial combination antiretroviral therapy for HIV (EuroCoord-CHAIN joint project): a … L Wittkop, HF Günthard, F De Wolf, D Dunn, A Cozzi-Lepri, A De Luca, ... The Lancet infectious diseases 11 (5), 363-371, 2011 | 397 | 2011 |
| HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance RW Shafer, SY Rhee, D Pillay, V Miller, P Sandstrom, JM Schapiro, ... AIDS (London, England) 21 (2), 215, 2007 | 386 | 2007 |
| Impact of HIV-1 subtype and antiretroviral therapy on protease and reverse transcriptase genotype: results of a global collaboration R Kantor, DA Katzenstein, B Efron, AP Carvalho, B Wynhoven, P Cane, ... PLoS Med 2 (4), e112, 2005 | 367 | 2005 |
| Update of the drug resistance mutations in HIV-1: March 2013 VA Johnson, V Calvez, HF Günthard, R Paredes, D Pillay, RW Shafer, ... Topics in antiviral medicine 21 (1), 6, 2013 | 309 | 2013 |
| Virological monitoring and resistance to first-line highly active antiretroviral therapy in adults infected with HIV-1 treated under WHO guidelines: a systematic review and … RK Gupta, A Hill, AW Sawyer, A Cozzi-Lepri, V von Wyl, S Yerly, VD Lima, ... The Lancet infectious diseases 9 (7), 409-417, 2009 | 296 | 2009 |
| Genetic analysis reveals the complex structure of HIV-1 transmission within defined risk groups S Hué, D Pillay, JP Clewley, OG Pybus Proceedings of the National Academy of Sciences 102 (12), 4425-4429, 2005 | 268 | 2005 |
| HIV-1 pol gene variation is sufficient for reconstruction of transmissions in the era of antiretroviral therapy S Hué, JP Clewley, PA Cane, D Pillay Aids 18 (5), 719-728, 2004 | 243 | 2004 |
| Estimating excess 1-year mortality associated with the COVID-19 pandemic according to underlying conditions and age: a population-based cohort study A Banerjee, L Pasea, S Harris, A Gonzalez-Izquierdo, A Torralbo, ... The Lancet 395 (10238), 1715-1725, 2020 | 242 | 2020 |
| Emergence of drug resistance in HIV type 1-infected patients after receipt of first-line highly active antiretroviral therapy: a systematic review of clinical trials R Gupta, A Hill, AW Sawyer, D Pillay Clinical infectious diseases 47 (5), 712-722, 2008 | 240 | 2008 |
| An open-label study of tenofovir in HIV-1 and hepatitis B virus co-infected individuals M Nelson, S Portsmouth, J Stebbing, M Atkins, A Barr, G Matthews, ... Aids 17 (1), F7-F10, 2003 | 229 | 2003 |
| Update of the drug resistance mutations in HIV-1: 2007 VA Johnson, F Brun-Vézinet, B Clotet, HF Gunthard, DR Kuritzkes, ... Top HIV Med 15 (4), 119-125, 2007 | 226 | 2007 |
| HIV-1 drug resistance before initiation or re-initiation of first-line antiretroviral therapy in low-income and middle-income countries: a systematic review and meta-regression … RK Gupta, J Gregson, N Parkin, H Haile-Selassie, A Tanuri, LA Forero, ... The Lancet infectious diseases 18 (3), 346-355, 2018 | 220 | 2018 |
| Time trends in primary resistance to HIV drugs in the United Kingdom: multicentre observational study UK Group on Transmitted HIV Drug Resistance Bmj 331 (7529), 1368, 2005 | 216 | 2005 |
